The clinical significance of the role of CaV1.2 in hippocampus dependent behaviours is strengthened by the fact that, CACNA1C is consistently identified as a prominent risk gene in large-scale genome-wide association studies for mental and psychiatric diseases with cognitive or social impairments such as depression, schizophrenia and bipolar disorders [22]. This evidence concerns the gene CACNA1C and major depressive disorder.